Literature DB >> 20411621

Does upsizing statins have a downside?

Andrew J Brown.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 20411621     DOI: 10.2165/11532370-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  5 in total

1.  The search beyond statins.

Authors:  Melinda Wenner Moyer
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

2.  Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.

Authors:  Eric Bruckert; Gilles Hayem; Sylvie Dejager; Caroline Yau; Bernard Bégaud
Journal:  Cardiovasc Drugs Ther       Date:  2005-12       Impact factor: 3.727

Review 3.  Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.

Authors:  Yiannis S Chatzizisis; Konstantinos C Koskinas; Gesthimani Misirli; Christos Vaklavas; Apostolos Hatzitolios; George D Giannoglou
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

4.  Gaps in cardiovascular disease risk management in Australian general practice.

Authors:  Ruth J Webster; Emma L Heeley; David P Peiris; Clare Bayram; Alan Cass; Anushka A Patel
Journal:  Med J Aust       Date:  2009-09-21       Impact factor: 7.738

Review 5.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.